For research use only. Not for therapeutic Use.
STING Agonist 1a is a potent stimulator of the stimulator of interferon genes (STING) pathway, which plays a key role in the innate immune response. It is being investigated for its potential in cancer immunotherapy and infectious diseases. By activating STING, it enhances the production of type I interferons and other cytokines, promoting anti-tumor immunity and improving immune responses. STING Agonist 1a holds promise as a therapeutic agent for enhancing immune system activation in cancer and viral infections.
Catalog Number | I036717 |
CAS Number | 652142-94-4 |
Synonyms | STING Agonist 1a; STING Agonist-1a; |
Molecular Formula | C19H11Cl2N5O |
Purity | 98% |
Target | STING |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
IUPAC Name | 4-chloro-1-(2-chloro-6-methoxyquinolin-3-yl)-[1,2,4]triazolo[4,3-a]quinoxaline |
InChI | InChI=1S/C19H11Cl2N5O/c1-27-11-6-7-13-10(8-11)9-12(16(20)22-13)18-24-25-19-17(21)23-14-4-2-3-5-15(14)26(18)19/h2-9H,1H3 |
InChIKey | ABGPUQXRCXUIFE-UHFFFAOYSA-N |
SMILES | ClC1=NC2=C(C=CC=C2)N3C1=NN=C3C4=C(N=C5C=CC(OC)=CC5=C4)Cl |